For licensed medical professionals and compounding pharmacies only. Not for sale to the general public.  ·  787-822-8197
Build Your Order Apply for Wholesale
Build Your Order Products For Clinics For Pharmacies For Brands Quality Wholesale Resources About Contact Apply for Wholesale
Licensed clinic purchasing

Wholesale peptide sourcing for medical weight loss clinics.

Weight-loss practices need a sourcing plan that matches today’s rules—not assumptions carried over from the GLP-1 shortage. Confirm the product pathway first, then plan purchasing around documented availability and usable inventory.

Medical weight-loss clinic with GLP-1 injectable vials on an exam-room counter
Apply for a clinic accountRequest a sourcing review

Recheck GLP-1 sourcing after the shortage

FDA’s April 1, 2026 update states that semaglutide and tirzepatide do not appear on the 503B bulks list or FDA’s shortage list. A local backorder does not recreate the federal shortage exception. This page does not offer routine 503B bulk-compounded semaglutide or tirzepatide supply. See the post-shortage sourcing guide and official sources below.

Separate patient prescriptions from office inventory

A patient-specific prescription pathway is not an interchangeable way to buy general office stock. Have the prescriber and dispensing or supplying entity confirm the requirements for the actual preparation and state. Adding another ingredient is not, by itself, a blanket exemption from restrictions on essentially copies.

Forecast by exact presentation

Track each approved formulation, concentration, and package separately. Use actual consumption and scheduled demand reviewed by the clinical team, not total patient count alone. Our weight-loss inventory guide explains reorder points and shelf-life limits without prescribing doses.

Require a written supply and exception plan

Before accepting a quote, confirm the authorized source, specific product, shipment window, receiving requirements, and handling of unavailable or damaged stock. Do not approve a substitution based only on a similar name or a salesperson’s recommendation. Any treatment change belongs with the clinician.

Product information for your sourcing review

Use these catalog references to identify questions, not as confirmation of stock or authorization to purchase for treatment. Product-specific regulatory review takes priority over catalog labels.

Clinic purchasing guides

Compare the supplier checklist resource and our testing documentation guidance when preparing your questions.

Questions from medical weight loss clinics

No. A local availability problem is not the same as a drug’s inclusion on FDA’s shortage list. Check current FDA guidance and the exact legal pathway with qualified reviewers.

No. This is a purchasing and regulatory information page, not a live inventory feed or an offer of routine 503B bulk-compounded GLP-1 supply.

Forecast by exact presentation, subtract usable stock and confirmed inbound inventory, and cap orders at the quantity expected to be used before the applicable expiry or beyond-use date.

Regulatory sources and purchasing limits

Compounded drugs are not FDA-approved. Facility registration does not establish approval or eligibility for every preparation. Verify the exact product, source, applicable federal requirements, and state rules before ordering. This is procurement education, not medical or legal advice.

Compare requirements across all clinic specialties.

Tell us what your clinic needs.

Send your facility details, destination state, exact product requirements, and expected volume. Availability and order terms require review.

Apply for a clinic accountRequest a sourcing review

Compare exact product references

Use these pages to prepare specific identity and documentation questions. Inclusion here does not establish clinical suitability, stock or permission to purchase for treatment.

Call Apply for Wholesale